Intravenous pamidronate for refractory lymphedema

Iranian Red Crescent Medical Journal

Volumn 13, Issue 4, 2011, Pages 263-266

  Beigi, A A ^a   Sadeghi, A M ^b   Masoudpour, H ^a   Shirazinejad, S ^a   Mottaghi, P ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Bisphosphonate; Pamidronate; Refractory lymphedema

Indexed keywords

PAMIDRONIC ACID;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; LIMB CIRCUMFERENCE; LIMB VOLUME; LYMPHEDEMA; MALE; MYALGIA; PATIENT SATISFACTION; VISUAL ANALOG SCALE;

EID: 79954493669     PISSN: 20741804     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Petrek JA, Pressman PI, Smith RA. Lymphedema: Current issues in research and management. CA Cancer J Clin 2000;50:292-307. [11075239] [doi:10.3322/canjclin.50.5.292]
2. Rockson SG. Lymphedema. Am J Med 2001;110:288-95. [11239847] [doi:10.1016/S0002-9343(00)00727-0]
3. Szuba A, Rockson SG. Lymphedema: classification, diagnosis and therapy. Vasc Med 1998;3:145-56. [9796078]
4. Farncombe M, Daniels G, Cross L. Lymphedema: The seemingly forgotten complication. J Pain Symptom Manage 1994;9:269-76. [8089544] [doi:10.1016/0885-3924(94)90105-8]
5. Weissldr H, Schuchardt C. Physiology (fundamentals). In: Weissleder H, Schuchardt C, editors. Lymphedema: Diagnosis and therapy. 3rd edition. Cologne: Viavital Verlag, 2001; p. 25-34.
6. Weissldr H, Schuchardt C. Lymphedema of the arm following breast cancer therapy. In: Weissleder H, Schuchardt C, editors. Lymphedema: Diagnosis and therapy. 3rd ed. Cologne: Viavital Verlag, 2001; p. 187-213.
7. Weissldr H, Schuchardt C. Lymphedema following therapy of head and neck malignancies. In: Weissleder H, Schuchardt C, editors. Lymphedema: Diagnosis and therapy. 3rd ed. Cologne: Viavital Verlag, 2001; p. 222-230.
8. Paskett ED, Stark N. Lymphedema: Knowledge, treatment, and impact among breast cancer survivors. Breast J 2000;6:373-378.
9. Szuba A, Rockson SG. Lymphedema: anatomy, physiology and pathogenesis. Vasc Med 1997;2:321-6. [9575606]
10. Micke O, Bruns F, Mücke R, Schäfer U, Glatzel M, DeVries AF, Schönekaes K, Kisters K, Büntzel J. Selenium in the treatment of radiation associated secondary lymphedema. Int J Radiat Oncol Biol Phys 2003;56:40-9. [12694822] [doi:10.1016/S0360-3016(02)04390-0]
11. Browse NL, Stewart G. Lymphedma: Pathophysiology and classification. J Cardiovasc Surg (Torino) 1985;26:91-106. [3884629]
12. Kocak Z, Overgaard J. Risk factors of arm lymphedema in breast cancer patients. Acta Oncol 2000;39:389-92. [10987236] [doi:10.1080/028418600750013168]
13. Megens A, Harris SR. Physical therapist management of lymphedema following treatment for breast cancer: a critical review of its effectiveness. Phys Ther 1998;78:1302-11. [9859949]
14. Földi E. The treatment of lymphedema. Cancer 1998;83:2833-4. [9874407] [doi:10.1002/(SICI)1097-0142(19981215)83:12B+<2833::AID-CNCR35>3.0.CO;2-3]
15. Kasserroller RG, Schruzer GN. Treatment of secondary lymphedema of the arm with physical decongestive therapy and sodium selenite: a review. Am J Ther 2000;7:273-9. [11486162] [doi:10.1097/00045391-200007040-00008]
16. Micke O, Bruns F, Schäfer U, Kisters K, Hesselmann S, Willich N. Selenium in the treatment of acute and chronic lymphedema. Trace Elem Electrolytes 2000;17:206-9.
17. Kasseroller R. Sodium selenite as prophylaxis against erysipelas in secondary lymphedema. Anticancer Res 1998;18:2227-30. [9703790]
18. Brenke R, Siems W, Grune T. Measures for therapy optimization in chronic lymphedema. Z Lymphol 1997;21:1-29.
19. Caseley-Smith JR. Benzo-pyrones in the treatment of lymphedema. Int Angiol 1999;18:31-41. [10392478]
20. Casley-Smith JR, Morgan RG, Piller NB. T Treatment of lymphedema of the arms and legs with 5,6-benzo-[alpha]-pyrone. N Engl J Med 1993;329:1158-63. [8377779] [doi:10.1056/NEJM199310143291604]
21. Schuchardt C, Pritschow H, Weissleder H. Conservative treatment. In: Weissleder H, Schuchardt C, editors. Lymphedema: Diagnosis and therapy. 3rd ed. Cologne: Viavital Verlag, 2001; p.: 336-358.
22. Maillefert JF, Chatard C, Owen S, Peere T, Tavernier C, Tebib J. Treatment of refractory reflex sympathetic dystrophy with pamidronate. Ann Rheum Dis 1995;54:687. [7677451] [doi:10.1136/ard.54.8.687-a]
23. Miettunen PMH, Joughin E. Effective use of pamidronate in severe reflex sympathetic dystrophy. Ann Rheum Dis 2006;65:444.
24. Schott GD. Bisphoshonates for pain relief in reflex sympathetic dystrophy. Lancet 1997;350:1117. [9343496] [doi:10.1016/S0140-6736(05)63785-3]
25. Siminoski K, Fitzgerald AA, Flesch G, Gross MS. Intravenous pamidronate for treatment of reflex sympathetic dystrophy during breast feeding. J Bone Miner Res 2000;15:2052-5. [11028460] [doi:10.1359/jbmr.2000.15.10.2052]